Gene therapy developers are striving to platform their process development to more quickly and cost-effectively bring their drugs to market, meaning optimizing upstream process development
Are you looking to meet with all the key decision makers in the covalent space, including CXOs, VPs and Directors of Medicinal, Discovery, and Biological Chemistry?